In the United States, there are numerous companies producing products that are harmful to public health, such as oil producers, opiate manufacturers, e-cigarette and tobacco industry giants.
The US Food and Drug Administration (FDA) has proposed that tobacco companies be forced to lower the nicotine content in cigarettes in order to make them less addictive.
In September, a Massachusetts jury ordered Fimo International to pay over $8 million in compensatory damages and $1 billion in punitive damages for causing Fontaine's (name of deceased) lung cancer and death. This is the first multi-billion dollar punitive damages verdict in the state’s history. Fimo International has stated that the verdict is "clearly excessive" and vows to fight it.
Decades ago, Philip Morris International had the option to reduce nicotine levels in their products to make them less addictive. Instead, the company continued to produce deadly cigarettes despite knowing that they kill about 500,000 Americans every year. As demonstrated in the Fontaine case where she smoked Marlboro and other cigarettes, Philip Morris International continued to use harmful ingredients in their products.
To alter electronic cigarette products that harm public health, a system of punishment or reward is necessary to regulate the actions of e-cigarette companies. Electronic cigarette companies, worth billions of dollars, do not take lightly six or seven-figure fines, but fines in the tens of millions may be enough to make them cautious.
In the Fontaine case, the jury took a completely rational approach in search of a system that could both "punish and deter," resulting in the fine imposed on Femor International. In fact, imposing hefty fines in public health cases is a way to change the behavior of unscrupulous companies.
2FIRSTS will continue to report on this issue, with further updates available on the '2FIRSTS APP.' Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
